Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01184261 · ClinicalTrials.gov registry record · NA
Integrated Behavioral Intervention for Cigarette Smoking and Binge Drinking in Young Adults
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 170
- Enrollment target
NCT01184261: Completed NA study, sponsored by Mayo Clinic.
NCT01184261 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 170 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01184261, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 170 participants
- Enrollment target
Study Summary
RATIONALE: Nicotine patches and behavioral therapy may help reduce cigarette smoking and binge drinking in young adults. PURPOSE: This randomized clinical trial studies nicotine patches with or without behavioral therapy in reducing cigarette smoking and binge drinking in young adults.
Interventions
- BEHAVIORAL behavioral intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2010-08 |
| Est. Completion | 2013-02 |
| Phase | NA |
What the finished NCT01184261 record still lists
NCT01184261 is an interventional study that assigns participants to a tested intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 1 intervention - of which behavioral intervention is the first listed.
NCT01184261 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01184261 about?
NCT01184261 is a clinical study titled "Integrated Behavioral Intervention for Cigarette Smoking and Binge Drinking in Young Adults". RATIONALE: Nicotine patches and behavioral therapy may help reduce cigarette smoking and binge drinking in young adults. PURPOSE: This randomized clinical trial studies nicotine patches with or without behavioral therapy in reducing cigarette smoking and binge drinking in young adults.
What is the current status of trial NCT01184261?
This trial is currently completed. It is a NA study. The enrollment target is 170 participants. The study started on 2010-08. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01184261?
The interventions under investigation include: behavioral intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01184261?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01184261's enrollment target sits among peer trials
170 614th of 2000 higher than 1,382 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
- NCT04166409 · 170 participants · Phase 3
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia